Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cellular and Gene Therapy CDMO Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Cell Therapy
1.2.3 Viral Vectors
1.2.4 Plasmid
1.3 Market by Application
1.3.1 Global Cellular and Gene Therapy CDMO Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Commercial
1.3.3 Academic Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cellular and Gene Therapy CDMO Market Perspective (2018-2033)
2.2 Cellular and Gene Therapy CDMO Growth Trends by Region
2.2.1 Global Cellular and Gene Therapy CDMO Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cellular and Gene Therapy CDMO Historic Market Size by Region (2018-2023)
2.2.3 Cellular and Gene Therapy CDMO Forecasted Market Size by Region (2024-2033)
2.3 Cellular and Gene Therapy CDMO Market Dynamics
2.3.1 Cellular and Gene Therapy CDMO Industry Trends
2.3.2 Cellular and Gene Therapy CDMO Market Drivers
2.3.3 Cellular and Gene Therapy CDMO Market Challenges
2.3.4 Cellular and Gene Therapy CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cellular and Gene Therapy CDMO Players by Revenue
3.1.1 Global Top Cellular and Gene Therapy CDMO Players by Revenue (2018-2023)
3.1.2 Global Cellular and Gene Therapy CDMO Revenue Market Share by Players (2018-2023)
3.2 Global Cellular and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cellular and Gene Therapy CDMO Revenue
3.4 Global Cellular and Gene Therapy CDMO Market Concentration Ratio
3.4.1 Global Cellular and Gene Therapy CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cellular and Gene Therapy CDMO Revenue in 2022
3.5 Cellular and Gene Therapy CDMO Key Players Head office and Area Served
3.6 Key Players Cellular and Gene Therapy CDMO Product Solution and Service
3.7 Date of Enter into Cellular and Gene Therapy CDMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cellular and Gene Therapy CDMO Breakdown Data by Type
4.1 Global Cellular and Gene Therapy CDMO Historic Market Size by Type (2018-2023)
4.2 Global Cellular and Gene Therapy CDMO Forecasted Market Size by Type (2024-2033)
5 Cellular and Gene Therapy CDMO Breakdown Data by Application
5.1 Global Cellular and Gene Therapy CDMO Historic Market Size by Application (2018-2023)
5.2 Global Cellular and Gene Therapy CDMO Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cellular and Gene Therapy CDMO Market Size (2018-2033)
6.2 North America Cellular and Gene Therapy CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Cellular and Gene Therapy CDMO Market Size by Country (2018-2023)
6.4 North America Cellular and Gene Therapy CDMO Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cellular and Gene Therapy CDMO Market Size (2018-2033)
7.2 Europe Cellular and Gene Therapy CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Cellular and Gene Therapy CDMO Market Size by Country (2018-2023)
7.4 Europe Cellular and Gene Therapy CDMO Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cellular and Gene Therapy CDMO Market Size (2018-2033)
8.2 Asia-Pacific Cellular and Gene Therapy CDMO Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Cellular and Gene Therapy CDMO Market Size by Region (2018-2023)
8.4 Asia-Pacific Cellular and Gene Therapy CDMO Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cellular and Gene Therapy CDMO Market Size (2018-2033)
9.2 Latin America Cellular and Gene Therapy CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Cellular and Gene Therapy CDMO Market Size by Country (2018-2023)
9.4 Latin America Cellular and Gene Therapy CDMO Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cellular and Gene Therapy CDMO Market Size (2018-2033)
10.2 Middle East & Africa Cellular and Gene Therapy CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Country (2018-2023)
10.4 Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Detail
11.1.2 Catalent Business Overview
11.1.3 Catalent Cellular and Gene Therapy CDMO Introduction
11.1.4 Catalent Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.1.5 Catalent Recent Development
11.2 Lonza
11.2.1 Lonza Company Detail
11.2.2 Lonza Business Overview
11.2.3 Lonza Cellular and Gene Therapy CDMO Introduction
11.2.4 Lonza Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.2.5 Lonza Recent Development
11.3 Charles River
11.3.1 Charles River Company Detail
11.3.2 Charles River Business Overview
11.3.3 Charles River Cellular and Gene Therapy CDMO Introduction
11.3.4 Charles River Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.3.5 Charles River Recent Development
11.4 The Discovery Labs
11.4.1 The Discovery Labs Company Detail
11.4.2 The Discovery Labs Business Overview
11.4.3 The Discovery Labs Cellular and Gene Therapy CDMO Introduction
11.4.4 The Discovery Labs Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.4.5 The Discovery Labs Recent Development
11.5 BIOCENTRIQ
11.5.1 BIOCENTRIQ Company Detail
11.5.2 BIOCENTRIQ Business Overview
11.5.3 BIOCENTRIQ Cellular and Gene Therapy CDMO Introduction
11.5.4 BIOCENTRIQ Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.5.5 BIOCENTRIQ Recent Development
11.6 FUJIFILM Diosynth Biotechnologies
11.6.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.6.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.6.3 FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Introduction
11.6.4 FUJIFILM Diosynth Biotechnologies Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.6.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.7 Exothera
11.7.1 Exothera Company Detail
11.7.2 Exothera Business Overview
11.7.3 Exothera Cellular and Gene Therapy CDMO Introduction
11.7.4 Exothera Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.7.5 Exothera Recent Development
11.8 WuXi AppTec
11.8.1 WuXi AppTec Company Detail
11.8.2 WuXi AppTec Business Overview
11.8.3 WuXi AppTec Cellular and Gene Therapy CDMO Introduction
11.8.4 WuXi AppTec Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.8.5 WuXi AppTec Recent Development
11.9 Pharmaron
11.9.1 Pharmaron Company Detail
11.9.2 Pharmaron Business Overview
11.9.3 Pharmaron Cellular and Gene Therapy CDMO Introduction
11.9.4 Pharmaron Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.9.5 Pharmaron Recent Development
11.10 OBiO
11.10.1 OBiO Company Detail
11.10.2 OBiO Business Overview
11.10.3 OBiO Cellular and Gene Therapy CDMO Introduction
11.10.4 OBiO Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.10.5 OBiO Recent Development
11.11 Cell Therapies
11.11.1 Cell Therapies Company Detail
11.11.2 Cell Therapies Business Overview
11.11.3 Cell Therapies Cellular and Gene Therapy CDMO Introduction
11.11.4 Cell Therapies Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.11.5 Cell Therapies Recent Development
11.12 AGC Biologics
11.12.1 AGC Biologics Company Detail
11.12.2 AGC Biologics Business Overview
11.12.3 AGC Biologics Cellular and Gene Therapy CDMO Introduction
11.12.4 AGC Biologics Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.12.5 AGC Biologics Recent Development
11.13 Cytiva
11.13.1 Cytiva Company Detail
11.13.2 Cytiva Business Overview
11.13.3 Cytiva Cellular and Gene Therapy CDMO Introduction
11.13.4 Cytiva Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.13.5 Cytiva Recent Development
11.14 Helixmith
11.14.1 Helixmith Company Detail
11.14.2 Helixmith Business Overview
11.14.3 Helixmith Cellular and Gene Therapy CDMO Introduction
11.14.4 Helixmith Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.14.5 Helixmith Recent Development
11.15 ThermoGenesis
11.15.1 ThermoGenesis Company Detail
11.15.2 ThermoGenesis Business Overview
11.15.3 ThermoGenesis Cellular and Gene Therapy CDMO Introduction
11.15.4 ThermoGenesis Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.15.5 ThermoGenesis Recent Development
11.16 Anemocyte
11.16.1 Anemocyte Company Detail
11.16.2 Anemocyte Business Overview
11.16.3 Anemocyte Cellular and Gene Therapy CDMO Introduction
11.16.4 Anemocyte Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.16.5 Anemocyte Recent Development
11.17 Thermo Fisher Scientific
11.17.1 Thermo Fisher Scientific Company Detail
11.17.2 Thermo Fisher Scientific Business Overview
11.17.3 Thermo Fisher Scientific Cellular and Gene Therapy CDMO Introduction
11.17.4 Thermo Fisher Scientific Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.17.5 Thermo Fisher Scientific Recent Development
11.18 CBM
11.18.1 CBM Company Detail
11.18.2 CBM Business Overview
11.18.3 CBM Cellular and Gene Therapy CDMO Introduction
11.18.4 CBM Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.18.5 CBM Recent Development
11.19 Bio Elpida
11.19.1 Bio Elpida Company Detail
11.19.2 Bio Elpida Business Overview
11.19.3 Bio Elpida Cellular and Gene Therapy CDMO Introduction
11.19.4 Bio Elpida Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.19.5 Bio Elpida Recent Development
11.20 Genezen
11.20.1 Genezen Company Detail
11.20.2 Genezen Business Overview
11.20.3 Genezen Cellular and Gene Therapy CDMO Introduction
11.20.4 Genezen Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.20.5 Genezen Recent Development
11.21 CCRM
11.21.1 CCRM Company Detail
11.21.2 CCRM Business Overview
11.21.3 CCRM Cellular and Gene Therapy CDMO Introduction
11.21.4 CCRM Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.21.5 CCRM Recent Development
11.22 RoslinCT
11.22.1 RoslinCT Company Detail
11.22.2 RoslinCT Business Overview
11.22.3 RoslinCT Cellular and Gene Therapy CDMO Introduction
11.22.4 RoslinCT Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.22.5 RoslinCT Recent Development
11.23 GenScript ProBio
11.23.1 GenScript ProBio Company Detail
11.23.2 GenScript ProBio Business Overview
11.23.3 GenScript ProBio Cellular and Gene Therapy CDMO Introduction
11.23.4 GenScript ProBio Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.23.5 GenScript ProBio Recent Development
11.24 Oxford BioMedica
11.24.1 Oxford BioMedica Company Detail
11.24.2 Oxford BioMedica Business Overview
11.24.3 Oxford BioMedica Cellular and Gene Therapy CDMO Introduction
11.24.4 Oxford BioMedica Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.24.5 Oxford BioMedica Recent Development
11.25 Porton Pharma Solutions
11.25.1 Porton Pharma Solutions Company Detail
11.25.2 Porton Pharma Solutions Business Overview
11.25.3 Porton Pharma Solutions Cellular and Gene Therapy CDMO Introduction
11.25.4 Porton Pharma Solutions Revenue in Cellular and Gene Therapy CDMO Business (2018-2023)
11.25.5 Porton Pharma Solutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cellular and Gene Therapy CDMO Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Viral Vectors
Table 4. Key Players of Plasmid
Table 5. Global Cellular and Gene Therapy CDMO Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Cellular and Gene Therapy CDMO Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Cellular and Gene Therapy CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Cellular and Gene Therapy CDMO Market Share by Region (2018-2023)
Table 9. Global Cellular and Gene Therapy CDMO Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Cellular and Gene Therapy CDMO Market Share by Region (2024-2033)
Table 11. Cellular and Gene Therapy CDMO Market Trends
Table 12. Cellular and Gene Therapy CDMO Market Drivers
Table 13. Cellular and Gene Therapy CDMO Market Challenges
Table 14. Cellular and Gene Therapy CDMO Market Restraints
Table 15. Global Cellular and Gene Therapy CDMO Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Cellular and Gene Therapy CDMO Market Share by Players (2018-2023)
Table 17. Global Top Cellular and Gene Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular and Gene Therapy CDMO as of 2022)
Table 18. Ranking of Global Top Cellular and Gene Therapy CDMO Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Cellular and Gene Therapy CDMO Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cellular and Gene Therapy CDMO Product Solution and Service
Table 22. Date of Enter into Cellular and Gene Therapy CDMO Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cellular and Gene Therapy CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Cellular and Gene Therapy CDMO Revenue Market Share by Type (2018-2023)
Table 26. Global Cellular and Gene Therapy CDMO Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Cellular and Gene Therapy CDMO Revenue Market Share by Type (2024-2033)
Table 28. Global Cellular and Gene Therapy CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Cellular and Gene Therapy CDMO Revenue Market Share by Application (2018-2023)
Table 30. Global Cellular and Gene Therapy CDMO Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Cellular and Gene Therapy CDMO Revenue Market Share by Application (2024-2033)
Table 32. North America Cellular and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Cellular and Gene Therapy CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Cellular and Gene Therapy CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Cellular and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Cellular and Gene Therapy CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Cellular and Gene Therapy CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Cellular and Gene Therapy CDMO Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Cellular and Gene Therapy CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Cellular and Gene Therapy CDMO Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Cellular and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Cellular and Gene Therapy CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Cellular and Gene Therapy CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Cellular and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 47. Catalent Company Detail
Table 48. Catalent Business Overview
Table 49. Catalent Cellular and Gene Therapy CDMO Product
Table 50. Catalent Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 51. Catalent Recent Development
Table 52. Lonza Company Detail
Table 53. Lonza Business Overview
Table 54. Lonza Cellular and Gene Therapy CDMO Product
Table 55. Lonza Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 56. Lonza Recent Development
Table 57. Charles River Company Detail
Table 58. Charles River Business Overview
Table 59. Charles River Cellular and Gene Therapy CDMO Product
Table 60. Charles River Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 61. Charles River Recent Development
Table 62. The Discovery Labs Company Detail
Table 63. The Discovery Labs Business Overview
Table 64. The Discovery Labs Cellular and Gene Therapy CDMO Product
Table 65. The Discovery Labs Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 66. The Discovery Labs Recent Development
Table 67. BIOCENTRIQ Company Detail
Table 68. BIOCENTRIQ Business Overview
Table 69. BIOCENTRIQ Cellular and Gene Therapy CDMO Product
Table 70. BIOCENTRIQ Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 71. BIOCENTRIQ Recent Development
Table 72. FUJIFILM Diosynth Biotechnologies Company Detail
Table 73. FUJIFILM Diosynth Biotechnologies Business Overview
Table 74. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Product
Table 75. FUJIFILM Diosynth Biotechnologies Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 76. FUJIFILM Diosynth Biotechnologies Recent Development
Table 77. Exothera Company Detail
Table 78. Exothera Business Overview
Table 79. Exothera Cellular and Gene Therapy CDMO Product
Table 80. Exothera Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 81. Exothera Recent Development
Table 82. WuXi AppTec Company Detail
Table 83. WuXi AppTec Business Overview
Table 84. WuXi AppTec Cellular and Gene Therapy CDMO Product
Table 85. WuXi AppTec Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 86. WuXi AppTec Recent Development
Table 87. Pharmaron Company Detail
Table 88. Pharmaron Business Overview
Table 89. Pharmaron Cellular and Gene Therapy CDMO Product
Table 90. Pharmaron Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 91. Pharmaron Recent Development
Table 92. OBiO Company Detail
Table 93. OBiO Business Overview
Table 94. OBiO Cellular and Gene Therapy CDMO Product
Table 95. OBiO Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 96. OBiO Recent Development
Table 97. Cell Therapies Company Detail
Table 98. Cell Therapies Business Overview
Table 99. Cell Therapies Cellular and Gene Therapy CDMO Product
Table 100. Cell Therapies Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 101. Cell Therapies Recent Development
Table 102. AGC Biologics Company Detail
Table 103. AGC Biologics Business Overview
Table 104. AGC Biologics Cellular and Gene Therapy CDMO Product
Table 105. AGC Biologics Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 106. AGC Biologics Recent Development
Table 107. Cytiva Company Detail
Table 108. Cytiva Business Overview
Table 109. Cytiva Cellular and Gene Therapy CDMO Product
Table 110. Cytiva Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 111. Cytiva Recent Development
Table 112. Helixmith Company Detail
Table 113. Helixmith Business Overview
Table 114. Helixmith Cellular and Gene Therapy CDMO Product
Table 115. Helixmith Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 116. Helixmith Recent Development
Table 117. ThermoGenesis Company Detail
Table 118. ThermoGenesis Business Overview
Table 119. ThermoGenesis Cellular and Gene Therapy CDMO Product
Table 120. ThermoGenesis Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 121. ThermoGenesis Recent Development
Table 122. Anemocyte Company Detail
Table 123. Anemocyte Business Overview
Table 124. Anemocyte Cellular and Gene Therapy CDMO Product
Table 125. Anemocyte Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 126. Anemocyte Recent Development
Table 127. Thermo Fisher Scientific Company Detail
Table 128. Thermo Fisher Scientific Business Overview
Table 129. Thermo Fisher Scientific Cellular and Gene Therapy CDMO Product
Table 130. Thermo Fisher Scientific Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 131. Thermo Fisher Scientific Recent Development
Table 132. CBM Company Detail
Table 133. CBM Business Overview
Table 134. CBM Cellular and Gene Therapy CDMO Product
Table 135. CBM Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 136. CBM Recent Development
Table 137. Bio Elpida Company Detail
Table 138. Bio Elpida Business Overview
Table 139. Bio Elpida Cellular and Gene Therapy CDMO Product
Table 140. Bio Elpida Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 141. Bio Elpida Recent Development
Table 142. Genezen Company Detail
Table 143. Genezen Business Overview
Table 144. Genezen Cellular and Gene Therapy CDMO Product
Table 145. Genezen Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 146. Genezen Recent Development
Table 147. CCRM Company Detail
Table 148. CCRM Business Overview
Table 149. CCRM Cellular and Gene Therapy CDMO Product
Table 150. CCRM Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 151. CCRM Recent Development
Table 152. RoslinCT Company Detail
Table 153. RoslinCT Business Overview
Table 154. RoslinCT Cellular and Gene Therapy CDMO Product
Table 155. RoslinCT Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 156. RoslinCT Recent Development
Table 157. GenScript ProBio Company Detail
Table 158. GenScript ProBio Business Overview
Table 159. GenScript ProBio Cellular and Gene Therapy CDMO Product
Table 160. GenScript ProBio Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 161. GenScript ProBio Recent Development
Table 162. Oxford BioMedica Company Detail
Table 163. Oxford BioMedica Business Overview
Table 164. Oxford BioMedica Cellular and Gene Therapy CDMO Product
Table 165. Oxford BioMedica Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 166. Oxford BioMedica Recent Development
Table 167. Porton Pharma Solutions Company Detail
Table 168. Porton Pharma Solutions Business Overview
Table 169. Porton Pharma Solutions Cellular and Gene Therapy CDMO Product
Table 170. Porton Pharma Solutions Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 171. Porton Pharma Solutions Recent Development
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cellular and Gene Therapy CDMO Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Cellular and Gene Therapy CDMO Market Share by Type: 2022 VS 2033
Figure 3. Cell Therapy Features
Figure 4. Viral Vectors Features
Figure 5. Plasmid Features
Figure 6. Global Cellular and Gene Therapy CDMO Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Cellular and Gene Therapy CDMO Market Share by Application: 2022 VS 2033
Figure 8. Commercial Case Studies
Figure 9. Academic Research Case Studies
Figure 10. Others Case Studies
Figure 11. Cellular and Gene Therapy CDMO Report Years Considered
Figure 12. Global Cellular and Gene Therapy CDMO Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Cellular and Gene Therapy CDMO Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Cellular and Gene Therapy CDMO Market Share by Region: 2022 VS 2033
Figure 15. Global Cellular and Gene Therapy CDMO Market Share by Players in 2022
Figure 16. Global Top Cellular and Gene Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular and Gene Therapy CDMO as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Cellular and Gene Therapy CDMO Revenue in 2022
Figure 18. North America Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Cellular and Gene Therapy CDMO Market Share by Country (2018-2033)
Figure 20. United States Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Cellular and Gene Therapy CDMO Market Share by Country (2018-2033)
Figure 24. Germany Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Cellular and Gene Therapy CDMO Market Share by Region (2018-2033)
Figure 32. China Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Cellular and Gene Therapy CDMO Market Share by Country (2018-2033)
Figure 40. Mexico Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Cellular and Gene Therapy CDMO Market Share by Country (2018-2033)
Figure 44. Turkey Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Catalent Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 47. Lonza Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 48. Charles River Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 49. The Discovery Labs Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 50. BIOCENTRIQ Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 51. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 52. Exothera Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 53. WuXi AppTec Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 54. Pharmaron Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 55. OBiO Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 56. Cell Therapies Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 57. AGC Biologics Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 58. Cytiva Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 59. Helixmith Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 60. ThermoGenesis Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 61. Anemocyte Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 63. CBM Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 64. Bio Elpida Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 65. Genezen Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 66. CCRM Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 67. RoslinCT Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 68. GenScript ProBio Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 69. Oxford BioMedica Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 70. Porton Pharma Solutions Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed